ROBO1-specific BiCAR-NK/T cells

ROBO1-specific BiCAR-NK/T cells · Asclepius Technology Company Group (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ROBO1-specific BiCAR-NK/T cells, covering 2019-04-30 to 2019-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor [Phase 1, Phase 2]